Mumbai, August 07, 2023: Lupin Digital Health , India s leading Cardiac Digital Therapeutics company, today announced the launch of its newest offering, LyfeTM Digital Heart Failure.
Mumbai, Baltimore, August 02, 2023: Global pharma major Lupin Limited today announced that its wholly-owned subsidiary, Novel Laboratories Inc., based in Somerset, New Jersey, has.
First-ever product launch in the inhalation segmentin Germany Frankfurt, Mumbai, July 21, 2023: Hormosan Pharma GmbH , Lupin s wholly-owned subsidiary in Germany,.
Mumbai, Baltimore, July 21, 2023:Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration under.
Mumbai, Baltimore, July 14, 2023: Global pharma major Lupin Limited today announced that its wholly-owned subsidiary, Lupin Inc., based in Somerset, New Jersey, has received approval.